Phase II study of high-dose dexamethasone-based association in acute and delayed high-dose cisplatin-induced emesis--JCOG study 9413.

Thirty-three patients with lung cancer receiving 80 mg m(-2) cisplatin were treated with high-dose dexamethasone (32 mg m(-2) on days 1-3, 16 mg m(-2) on day 4 and 8 mg m(-2) on day 5) combined with granisetron on day 1 and metoclopramide on days 2-5. Twenty-eight (85%) patients had no nausea or vom...

Descripción completa

Detalles Bibliográficos
Autores principales: Sekine, I., Nishiwaki, Y., Kakinuma, R., Kubota, K., Hojo, F., Matsumoto, T., Ohmatsu, H., Yokozaki, M., Goto, K., Miyamoto, T., Takafuji, J., Kodama, T.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1997
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2223781/
https://www.ncbi.nlm.nih.gov/pubmed/9218738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2223781/
https://www.ncbi.nlm.nih.gov/pubmed/9218738

Ejemplares similares